Items on this page may include news associated with the IGNITE network as well as other organizations in the field of human genetics and genomics.

All ()
ADOPT PGx News ()
GUARDD-US News ()
December 13, 2022News,

PGx ECHO Program

The University of Minnesota College of Pharmacy invites all actively practicing clinicians to join their Pharmacogenomics (PGx) ECHO project. PGx ECHO aims to improve health professionals’ confidence in using PGx […]...

November 10, 2021Education, News

NHGRI Fact Sheets about Genomics

The National Human Genome Research Institute (NHGRI) has produced this series of fact sheets to explain complex concepts in genomics research to a non-scientific audience. Teachers, students and the general […]...

March 21, 2019News

Evaluating Genomic Medicine Interventions

The IGNITE I Network funded six genomic medicine projects. Through varied interventions, Lori Orlando, M.D., and team hypothesized that synergies across projects could be leveraged to better understand participants’ experiences […]...

General

  • IGNITE’s GUARDD pilot study determines effects of testing genetic risk for kidney failure March 28, 2022
    The Implementing GeNomics In practice (IGNITE) Pragmatic Clinical Trials Network’s GUARDD-US study has published their main outcomes paper of the pilot study, whose aim is to determine the effect of returning Apolipoprotein L1 (APOL1) genetic risk information to hypertensive African ancestry patients. “Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals,” was published in JAMA Network Open in March 2022. Chronic kidney disease (CKD) affects 26 million US adults.1 Individuals of African ancestry have a ...
  • Could a Community-Based Approach to Genetic Testing Help African Americans Reduce Risks of Chronic Kidney Disease? March 25, 2022
    Mount Sinai, lead site for GUARDD-US, saw drops in blood pressure for hypertensive patients, supporting further trials and extensive community involvement Read More>>
  • IGNITE celebrates Medical Genetics Awareness Week March 23, 2022
    Natasha Petry, PharmD, MPH, BCACP, Pharmacogenomics Clinical Pharmacist at Sanford Imagenetics is part of Vanderbilt University’s clinical site with the IGNITE Network. Learn More About ACMG>>
  • UNC’s Joint Postdoctoral Fellowship in Clinical Ethics and the ELSI of Precision Medicine March 15, 2022
    IGNITE network affiliate, UNC Program for Precision Medicine in Health Care, has posted an opportunity for a joint postdoctoral position in clinical ethics & the ethical, legal, and social implications of precision medicine.  Learn More>>
  • RFA: Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) February 10, 2022
    This Funding Opportunity Announcement is intended to identify and support research projects by exceptionally promising Early Stage Investigators with a long-term career interest in pursuing innovative research in genomics. This opportunity is open to research in all areas relevant to the mission of NHGRI, including genomic sciences, genomic medicine, genomic data science, and ethical, legal, and social implications of genomics. Learn More>>
  • Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients’ Use of Genomic Information February 10, 2022
    The National Human Genome Research Institute has issued Notice of Special Interest NOT-HG-22-011 to encourage applications to develop and implement patient-facing genomic-based clinical informatics tools that facilitate or enhance patient-provider electronic communication, patient tracking and registry functions, patient self-management and support, provider electronic prescribing, test tracking, referral tracking, and health care decision-making. Read the Full Notice>> Please direct all inquiries to the Scientific/Research Contact: Ken Wiley, Jr., Ph.D. National Human Genome Research Institute (NHGRI) Division of Genomic Medicine Telephone: 301-435-5540 Email: ken.wiley@nih.gov
  • CAGPM’s MeTree software recommended by President’s Cancer Panel February 8, 2022
    Lori Orlando (Duke Center for Applied Genomics & Precision Medicine) and the MeTree team highlighted in the Panel’s Closing Gaps in Cancer Screening Report to President Biden Read More>>

ADOPT/GUARDD